ReP USP - Resultado da busca

Artigo de periodico
Enhanced saccharification levels of corn starch using as a strategy a novel amylolytic complex (AmyHb) from the thermophilic fungus Humicola brevis var. thermoidea in association with commercial enzyme (2024)
Marciano, Camila Langer; Almeida, Aline Pereira de; Bezerra, Fabiane Cruz; Giannesi, Giovana Cristina; Cabral, Hamilton; Polizeli, Maria De Lourdes Teixeira De Moraes; Ruller, Roberto; Masui, Douglas Chodi
Source: 3 Biotech. Unidades: FCFRP, FFCLRP, FMRP
Subjects: AMILASES, HIDRÓLISE, AMIDO, MILHO, FERMENTAÇÃO, FUNGOS TERMÓFILOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCIANO, Camila Langer et al. Enhanced saccharification levels of corn starch using as a strategy a novel amylolytic complex (AmyHb) from the thermophilic fungus Humicola brevis var. thermoidea in association with commercial enzyme. 3 Biotech, v. 14, n. 9, 2024Tradução . . Disponível em: https://doi.org/10.1007/s13205-024-04038-y. Acesso em: 18 maio 2025.
APA
Marciano, C. L., Almeida, A. P. de, Bezerra, F. C., Giannesi, G. C., Cabral, H., Polizeli, M. D. L. T. D. M., et al. (2024). Enhanced saccharification levels of corn starch using as a strategy a novel amylolytic complex (AmyHb) from the thermophilic fungus Humicola brevis var. thermoidea in association with commercial enzyme. 3 Biotech, 14( 9). doi:10.1007/s13205-024-04038-y
NLM
Marciano CL, Almeida AP de, Bezerra FC, Giannesi GC, Cabral H, Polizeli MDLTDM, Ruller R, Masui DC. Enhanced saccharification levels of corn starch using as a strategy a novel amylolytic complex (AmyHb) from the thermophilic fungus Humicola brevis var. thermoidea in association with commercial enzyme [Internet]. 3 Biotech. 2024 ; 14( 9):[citado 2025 maio 18 ] Available from: https://doi.org/10.1007/s13205-024-04038-y
Vancouver
Marciano CL, Almeida AP de, Bezerra FC, Giannesi GC, Cabral H, Polizeli MDLTDM, Ruller R, Masui DC. Enhanced saccharification levels of corn starch using as a strategy a novel amylolytic complex (AmyHb) from the thermophilic fungus Humicola brevis var. thermoidea in association with commercial enzyme [Internet]. 3 Biotech. 2024 ; 14( 9):[citado 2025 maio 18 ] Available from: https://doi.org/10.1007/s13205-024-04038-y
Artigo de periodico
Evaluation of the adherence to surgical antibiotic prophylaxis recommendations and associated factors in a University Hospital: a cross-sectional study (2024)
Pereira, Lucas Borges ; Feliciano, Cinara Silva; Bellissimo-Rodrigues, Fernando ; Pereira, Leonardo Régis Leira
Source: American Journal of Infection Control. Unidades: FMRP, FCFRP
Subjects: ANTIBIÓTICOS, HOSPITAIS UNIVERSITÁRIOS, INFECÇÃO DA FERIDA OPERATÓRIA, ESTUDOS TRANSVERSAIS, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Lucas Borges et al. Evaluation of the adherence to surgical antibiotic prophylaxis recommendations and associated factors in a University Hospital: a cross-sectional study. American Journal of Infection Control, v. 52, n. 11, p. 1320-1328, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.ajic.2024.07.004. Acesso em: 18 maio 2025.
APA
Pereira, L. B., Feliciano, C. S., Bellissimo-Rodrigues, F., & Pereira, L. R. L. (2024). Evaluation of the adherence to surgical antibiotic prophylaxis recommendations and associated factors in a University Hospital: a cross-sectional study. American Journal of Infection Control, 52( 11), 1320-1328. doi:10.1016/j.ajic.2024.07.004
NLM
Pereira LB, Feliciano CS, Bellissimo-Rodrigues F, Pereira LRL. Evaluation of the adherence to surgical antibiotic prophylaxis recommendations and associated factors in a University Hospital: a cross-sectional study [Internet]. American Journal of Infection Control. 2024 ; 52( 11): 1320-1328.[citado 2025 maio 18 ] Available from: https://doi.org/10.1016/j.ajic.2024.07.004
Vancouver
Pereira LB, Feliciano CS, Bellissimo-Rodrigues F, Pereira LRL. Evaluation of the adherence to surgical antibiotic prophylaxis recommendations and associated factors in a University Hospital: a cross-sectional study [Internet]. American Journal of Infection Control. 2024 ; 52( 11): 1320-1328.[citado 2025 maio 18 ] Available from: https://doi.org/10.1016/j.ajic.2024.07.004
Artigo de periodico
Development and characterization of new green propolis extract formulations as promising candidates to substitute for green propolis hydroalcoholic extract (2023)
Berretta, Andresa Aparecida ; Zamarrenho, Luana Gonçalves; Corrêa, Juliana Arcadepani; Lima, Jéssica Aparecida de; Borini, Giovanna Bonfante; Ambrosio, Sérgio Ricardo ; Barud, Hernane da Silva ; Bastos, Jairo Kenupp ; De Jong, David
Source: Molecules. Unidades: IQSC, FCFRP, FMRP, FFCLRP
Subjects: EXTRATOS (FORMAS FARMACÊUTICAS), MICROENCAPSULAÇÃO, PRÓPOLIS, ANTIOXIDANTES, COMPOSTOS FENÓLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERRETTA, Andresa Aparecida et al. Development and characterization of new green propolis extract formulations as promising candidates to substitute for green propolis hydroalcoholic extract. Molecules, v. 28, n. 8, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.3390/molecules28083510. Acesso em: 18 maio 2025.
APA
Berretta, A. A., Zamarrenho, L. G., Corrêa, J. A., Lima, J. A. de, Borini, G. B., Ambrosio, S. R., et al. (2023). Development and characterization of new green propolis extract formulations as promising candidates to substitute for green propolis hydroalcoholic extract. Molecules, 28( 8), 1-17. doi:10.3390/molecules28083510
NLM
Berretta AA, Zamarrenho LG, Corrêa JA, Lima JA de, Borini GB, Ambrosio SR, Barud H da S, Bastos JK, De Jong D. Development and characterization of new green propolis extract formulations as promising candidates to substitute for green propolis hydroalcoholic extract [Internet]. Molecules. 2023 ; 28( 8): 1-17.[citado 2025 maio 18 ] Available from: https://doi.org/10.3390/molecules28083510
Vancouver
Berretta AA, Zamarrenho LG, Corrêa JA, Lima JA de, Borini GB, Ambrosio SR, Barud H da S, Bastos JK, De Jong D. Development and characterization of new green propolis extract formulations as promising candidates to substitute for green propolis hydroalcoholic extract [Internet]. Molecules. 2023 ; 28( 8): 1-17.[citado 2025 maio 18 ] Available from: https://doi.org/10.3390/molecules28083510
Artigo de periodico
Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? (2023)
Zanetti, Maria Olívia Barboza ; Rodrigues, João Paulo Vilela; Varallo, Fabiana Rossi ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto ; Pereira, Leonardo Régis Leira
Source: Journal of Oncology Pharmacy Practice. Unidades: EERP, FCFRP, FMRP
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, ADESÃO À MEDICAÇÃO, FARMACOTERAPIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Maria Olívia Barboza et al. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance?. Journal of Oncology Pharmacy Practice, v. 29, n. 2, p. 348-357, 2023Tradução . . Disponível em: https://doi.org/10.1177/10781552211073469. Acesso em: 18 maio 2025.
APA
Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? Journal of Oncology Pharmacy Practice, 29( 2), 348-357. doi:10.1177/10781552211073469
NLM
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 348-357.[citado 2025 maio 18 ] Available from: https://doi.org/10.1177/10781552211073469
Vancouver
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 348-357.[citado 2025 maio 18 ] Available from: https://doi.org/10.1177/10781552211073469
Artigo de periodico
Development and characterization of high-absorption microencapsulated organic propolis EPP-AF® extract (i-CAPs) (2023)
Berretta, Andresa Aparecida ; Lima, Jéssica Aparecida de; Falção, Soraia I.; Calhelha, Ricardo; Amorim, Nathaly Alcazar; Gonçalves, Isabella Salgado ; Zamarrenho, Luana Gonçalves; Barud, Hernane da Silva ; Bastos, Jairo Kenupp ; De Jong, David ; Vilas Boas, Miguel
Source: Molecules. Unidades: IQSC, FCFRP, FMRP, FFCLRP
Subjects: EXTRATOS (FORMAS FARMACÊUTICAS), PRÓPOLIS, ANTINEOPLÁSICOS, ANTIOXIDANTES, ANTI-INFLAMATÓRIOS, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERRETTA, Andresa Aparecida et al. Development and characterization of high-absorption microencapsulated organic propolis EPP-AF® extract (i-CAPs). Molecules, v. 28, n. 20, p. 1-25, 2023Tradução . . Disponível em: https://doi.org/10.3390/molecules28207128. Acesso em: 18 maio 2025.
APA
Berretta, A. A., Lima, J. A. de, Falção, S. I., Calhelha, R., Amorim, N. A., Gonçalves, I. S., et al. (2023). Development and characterization of high-absorption microencapsulated organic propolis EPP-AF® extract (i-CAPs). Molecules, 28( 20), 1-25. doi:10.3390/molecules28207128
NLM
Berretta AA, Lima JA de, Falção SI, Calhelha R, Amorim NA, Gonçalves IS, Zamarrenho LG, Barud H da S, Bastos JK, De Jong D, Vilas Boas M. Development and characterization of high-absorption microencapsulated organic propolis EPP-AF® extract (i-CAPs) [Internet]. Molecules. 2023 ; 28( 20): 1-25.[citado 2025 maio 18 ] Available from: https://doi.org/10.3390/molecules28207128
Vancouver
Berretta AA, Lima JA de, Falção SI, Calhelha R, Amorim NA, Gonçalves IS, Zamarrenho LG, Barud H da S, Bastos JK, De Jong D, Vilas Boas M. Development and characterization of high-absorption microencapsulated organic propolis EPP-AF® extract (i-CAPs) [Internet]. Molecules. 2023 ; 28( 20): 1-25.[citado 2025 maio 18 ] Available from: https://doi.org/10.3390/molecules28207128
Artigo de periodico
Effects of three different brazilian green propolis extract formulations on pro- and anti-inflammatory cytokine secretion by macrophages (2023)
Zamarrenho, Luana Gonçalves; Lima, Mikhael Haruo Fernandes de ; Hori, Juliana Issa; Lima, Jéssica Aparecida de; Ambrosio, Sérgio Ricardo ; Bastos, Jairo Kenupp ; De Jong, David ; Berretta, Andresa Aparecida
Source: Applied Sciences. Unidades: FCFRP, FMRP, FFCLRP
Subjects: EXTRATOS (FORMAS FARMACÊUTICAS), MICROENCAPSULAÇÃO, ANTIOXIDANTES, PRÓPOLIS, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMARRENHO, Luana Gonçalves et al. Effects of three different brazilian green propolis extract formulations on pro- and anti-inflammatory cytokine secretion by macrophages. Applied Sciences, v. 13, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.3390/app13106247. Acesso em: 18 maio 2025.
APA
Zamarrenho, L. G., Lima, M. H. F. de, Hori, J. I., Lima, J. A. de, Ambrosio, S. R., Bastos, J. K., et al. (2023). Effects of three different brazilian green propolis extract formulations on pro- and anti-inflammatory cytokine secretion by macrophages. Applied Sciences, 13, 1-17. doi:10.3390/app13106247
NLM
Zamarrenho LG, Lima MHF de, Hori JI, Lima JA de, Ambrosio SR, Bastos JK, De Jong D, Berretta AA. Effects of three different brazilian green propolis extract formulations on pro- and anti-inflammatory cytokine secretion by macrophages [Internet]. Applied Sciences. 2023 ; 13 1-17.[citado 2025 maio 18 ] Available from: https://doi.org/10.3390/app13106247
Vancouver
Zamarrenho LG, Lima MHF de, Hori JI, Lima JA de, Ambrosio SR, Bastos JK, De Jong D, Berretta AA. Effects of three different brazilian green propolis extract formulations on pro- and anti-inflammatory cytokine secretion by macrophages [Internet]. Applied Sciences. 2023 ; 13 1-17.[citado 2025 maio 18 ] Available from: https://doi.org/10.3390/app13106247
Artigo de periodico
Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs (2023)
Silvestrini, Ana Vitória Pupo ; Praça, Fabíola Garcia; Leite, Marcel Nani; Fantini, Marcia ; Frade, Marco Andrey Cipriani ; Bentley, M. V. L. B.
Source: International Journal of Pharmaceutics. Unidades: FCFRP, IF, FMRP
Subjects: BIOFÍSICA, MATERIAIS NANOESTRUTURADOS, ESPALHAMENTO DE RAIOS X A BAIXOS ÂNGULOS, CRISTAIS LÍQUIDOS, FARMACOLOGIA, PSORÍASE, GENÉTICA BIOQUÍMICA, RNA, TRIPTERYGIIDAE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVESTRINI, Ana Vitória Pupo et al. Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs. International Journal of Pharmaceutics, v. 640, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2023.123019. Acesso em: 18 maio 2025.
APA
Silvestrini, A. V. P., Praça, F. G., Leite, M. N., Fantini, M., Frade, M. A. C., & Bentley, M. V. L. B. (2023). Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs. International Journal of Pharmaceutics, 640. doi:10.1016/j.ijpharm.2023.123019
NLM
Silvestrini AVP, Praça FG, Leite MN, Fantini M, Frade MAC, Bentley MVLB. Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs [Internet]. International Journal of Pharmaceutics. 2023 ; 640[citado 2025 maio 18 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123019
Vancouver
Silvestrini AVP, Praça FG, Leite MN, Fantini M, Frade MAC, Bentley MVLB. Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs [Internet]. International Journal of Pharmaceutics. 2023 ; 640[citado 2025 maio 18 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123019
Artigo de periodico
Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team (2023)
Zanetti, Maria Olívia Barboza ; Rodrigues, João Paulo Vilela; Varallo, Fabiana Rossi ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto ; Pereira, Leonardo Régis Leira
Source: Journal of Oncology Pharmacy Practice. Unidades: EERP, FCFRP, FMRP
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, HOSPITALIZAÇÃO, SERVIÇOS FARMACÊUTICOS, FARMACOTERAPIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Maria Olívia Barboza et al. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, v. 29, n. 2, p. 375-385, 2023Tradução . . Disponível em: https://doi.org/10.1177/10781552211073797. Acesso em: 18 maio 2025.
APA
Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, 29( 2), 375-385. doi:10.1177/10781552211073797
NLM
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2025 maio 18 ] Available from: https://doi.org/10.1177/10781552211073797
Vancouver
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2025 maio 18 ] Available from: https://doi.org/10.1177/10781552211073797
Artigo de periodico
Coxiella co-opts the Glutathione Peroxidase 4 to protect the host cell from oxidative stress-induced cell death (2023)
Loterio, Robson Kriiger; Thomas, David R.; Andrade, Warrison Athanásio Coelho de; Lee, Yi Wei; Santos, Leonardo Lima dos ; Mascarenhas, Danielle Pini Alves; Steiner, Thiago M.; Chiaratto, Jéssica; Fielden, Laura F.; Lopes, Letícia; Bird, Lauren E.; Goldman, Gustavo Henrique ; Stojanovski, Diana; Scott, Nichollas E.; Zamboni, Dario Simões ; Newton, Hayley J.
Source: Proceedings National Academy of Sciences. Unidades: FMRP, FCFRP, FORP
Subjects: ANTIOXIDANTES, MORTE, ESTRESSE OXIDATIVO, FOSFOLIPÍDEOS, GLUTATIONA TRANSFERASE, PEROXIDASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTERIO, Robson Kriiger et al. Coxiella co-opts the Glutathione Peroxidase 4 to protect the host cell from oxidative stress-induced cell death. Proceedings National Academy of Sciences, v. 120, n. 36, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.1073/pnas.2308752120. Acesso em: 18 maio 2025.
APA
Loterio, R. K., Thomas, D. R., Andrade, W. A. C. de, Lee, Y. W., Santos, L. L. dos, Mascarenhas, D. P. A., et al. (2023). Coxiella co-opts the Glutathione Peroxidase 4 to protect the host cell from oxidative stress-induced cell death. Proceedings National Academy of Sciences, 120( 36), 1-11. doi:10.1073/pnas.2308752120
NLM
Loterio RK, Thomas DR, Andrade WAC de, Lee YW, Santos LL dos, Mascarenhas DPA, Steiner TM, Chiaratto J, Fielden LF, Lopes L, Bird LE, Goldman GH, Stojanovski D, Scott NE, Zamboni DS, Newton HJ. Coxiella co-opts the Glutathione Peroxidase 4 to protect the host cell from oxidative stress-induced cell death [Internet]. Proceedings National Academy of Sciences. 2023 ; 120( 36): 1-11.[citado 2025 maio 18 ] Available from: https://doi.org/10.1073/pnas.2308752120
Vancouver
Loterio RK, Thomas DR, Andrade WAC de, Lee YW, Santos LL dos, Mascarenhas DPA, Steiner TM, Chiaratto J, Fielden LF, Lopes L, Bird LE, Goldman GH, Stojanovski D, Scott NE, Zamboni DS, Newton HJ. Coxiella co-opts the Glutathione Peroxidase 4 to protect the host cell from oxidative stress-induced cell death [Internet]. Proceedings National Academy of Sciences. 2023 ; 120( 36): 1-11.[citado 2025 maio 18 ] Available from: https://doi.org/10.1073/pnas.2308752120
Artigo de periodico
Enzyme engineering and its industrial applications (2022)
Amatto, Isabela Victorino da Silva ; Garzon, Nathália Gonsales da Rosa ; Simões, Flávio Antônio de Oliveira; Santiago, Fernanda Luzia Borba; Leite, Nathália Pereira da Silva; Martins, Júlia Raspante; Cabral, Hamilton
Source: Biotechnology and Applied Biochemistry. Unidades: FCFRP, FMRP
Subjects: BIOTECNOLOGIA, CATÁLISE, ENZIMAS, APLICAÇÃO DO TESTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMATTO, Isabela Victorino da Silva et al. Enzyme engineering and its industrial applications. Biotechnology and Applied Biochemistry, v. 69, n. 2, p. 389-409, 2022Tradução . . Disponível em: https://doi.org/10.1002/bab.2117. Acesso em: 18 maio 2025.
APA
Amatto, I. V. da S., Garzon, N. G. da R., Simões, F. A. de O., Santiago, F. L. B., Leite, N. P. da S., Martins, J. R., & Cabral, H. (2022). Enzyme engineering and its industrial applications. Biotechnology and Applied Biochemistry, 69( 2), 389-409. doi:10.1002/bab.2117
NLM
Amatto IV da S, Garzon NG da R, Simões FA de O, Santiago FLB, Leite NP da S, Martins JR, Cabral H. Enzyme engineering and its industrial applications [Internet]. Biotechnology and Applied Biochemistry. 2022 ; 69( 2): 389-409.[citado 2025 maio 18 ] Available from: https://doi.org/10.1002/bab.2117
Vancouver
Amatto IV da S, Garzon NG da R, Simões FA de O, Santiago FLB, Leite NP da S, Martins JR, Cabral H. Enzyme engineering and its industrial applications [Internet]. Biotechnology and Applied Biochemistry. 2022 ; 69( 2): 389-409.[citado 2025 maio 18 ] Available from: https://doi.org/10.1002/bab.2117
Artigo de periodico
Chromatin profiling reveals heterogeneity in clinical isolates of the human pathogen Aspergillus fumigatus (2022)
Colabardini, Ana Cristina ; Wang, Fang; Miao, Zhengqiang; Pardeshi, Lakhansing; Fernández, Clara Isabel Valero ; Castro, Patrícia Alves de; Akiyama, Daniel Yuri; Tan, Kaeling; Nora, Luísa Czamanski ; Silva-Rocha, Rafael ; Marcet-Houben, Marina; Gabaldon, Toni; Fill, Taicia; Wong, Koon Ho; Goldman, Gustavo Henrique
Source: PLOS Genetics. Unidades: FMRP, FCFRP
Subjects: CROMATINA, GENOMAS, ASPERGILLUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COLABARDINI, Ana Cristina et al. Chromatin profiling reveals heterogeneity in clinical isolates of the human pathogen Aspergillus fumigatus. PLOS Genetics, v. 18, n. 1, p. 1-36, 2022Tradução . . Disponível em: https://doi.org/10.1371/journal.pgen.1010001. Acesso em: 18 maio 2025.
APA
Colabardini, A. C., Wang, F., Miao, Z., Pardeshi, L., Fernández, C. I. V., Castro, P. A. de, et al. (2022). Chromatin profiling reveals heterogeneity in clinical isolates of the human pathogen Aspergillus fumigatus. PLOS Genetics, 18( 1), 1-36. doi:10.1371/journal.pgen.1010001
NLM
Colabardini AC, Wang F, Miao Z, Pardeshi L, Fernández CIV, Castro PA de, Akiyama DY, Tan K, Nora LC, Silva-Rocha R, Marcet-Houben M, Gabaldon T, Fill T, Wong KH, Goldman GH. Chromatin profiling reveals heterogeneity in clinical isolates of the human pathogen Aspergillus fumigatus [Internet]. PLOS Genetics. 2022 ; 18( 1): 1-36.[citado 2025 maio 18 ] Available from: https://doi.org/10.1371/journal.pgen.1010001
Vancouver
Colabardini AC, Wang F, Miao Z, Pardeshi L, Fernández CIV, Castro PA de, Akiyama DY, Tan K, Nora LC, Silva-Rocha R, Marcet-Houben M, Gabaldon T, Fill T, Wong KH, Goldman GH. Chromatin profiling reveals heterogeneity in clinical isolates of the human pathogen Aspergillus fumigatus [Internet]. PLOS Genetics. 2022 ; 18( 1): 1-36.[citado 2025 maio 18 ] Available from: https://doi.org/10.1371/journal.pgen.1010001
Artigo de periodico
Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation (2022)
Bastos, Rafael Wesley; Akiyama, Daniel ; Reis, Thaila Fernanda dos ; Colabardini, Ana Cristina ; Luperini, Rafael Sanchez; Castro, Patrícia Alves de; Baldini, Regina Lúcia ; Fill, Taícia ; Goldman, Gustavo Henrique
Source: mBio. Unidades: FMRP, IQ, FCFRP
Subjects: METABÓLITOS SECUNDÁRIOS, PSEUDOMONAS, ASPERGILLUS, BIOFILMES, ANÓXIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTOS, Rafael Wesley et al. Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation. mBio, v. 13, n. 4, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.1128/mbio.01850-22. Acesso em: 18 maio 2025.
APA
Bastos, R. W., Akiyama, D., Reis, T. F. dos, Colabardini, A. C., Luperini, R. S., Castro, P. A. de, et al. (2022). Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation. mBio, 13( 4), 1-17. doi:10.1128/mbio.01850-22
NLM
Bastos RW, Akiyama D, Reis TF dos, Colabardini AC, Luperini RS, Castro PA de, Baldini RL, Fill T, Goldman GH. Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation [Internet]. mBio. 2022 ; 13( 4): 1-17.[citado 2025 maio 18 ] Available from: https://doi.org/10.1128/mbio.01850-22
Vancouver
Bastos RW, Akiyama D, Reis TF dos, Colabardini AC, Luperini RS, Castro PA de, Baldini RL, Fill T, Goldman GH. Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation [Internet]. mBio. 2022 ; 13( 4): 1-17.[citado 2025 maio 18 ] Available from: https://doi.org/10.1128/mbio.01850-22
Artigo de periodico
Heterogeneity in the transcriptional response of the human pathogen Aspergillus fumigatus to the antifungal agent caspofungin (2022)
Colabardini, Ana Cristina; Wang, Fang; Dong, Zhiqiang; Pardeshi, Lakhansing; Rocha, Marina Campos; Costa, Jonas Henrique; Reis, Thaila Fernanda dos ; Brown, Alec; Jaber, Qais Z; Fridman, Micha; Fill, Taicia; Rokas, Antonis; Malavazi, Iran; Wong, Koon Ho; Goldman, Gustavo Henrique
Source: Genetics. Unidades: FMRP, FCFRP
Subjects: ASPERGILLUS, ANTIFÚNGICOS, ASPERGILOSE ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COLABARDINI, Ana Cristina et al. Heterogeneity in the transcriptional response of the human pathogen Aspergillus fumigatus to the antifungal agent caspofungin. Genetics, v. 220, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1093/genetics/iyab183. Acesso em: 18 maio 2025.
APA
Colabardini, A. C., Wang, F., Dong, Z., Pardeshi, L., Rocha, M. C., Costa, J. H., et al. (2022). Heterogeneity in the transcriptional response of the human pathogen Aspergillus fumigatus to the antifungal agent caspofungin. Genetics, 220( 1). doi:10.1093/genetics/iyab183
NLM
Colabardini AC, Wang F, Dong Z, Pardeshi L, Rocha MC, Costa JH, Reis TF dos, Brown A, Jaber QZ, Fridman M, Fill T, Rokas A, Malavazi I, Wong KH, Goldman GH. Heterogeneity in the transcriptional response of the human pathogen Aspergillus fumigatus to the antifungal agent caspofungin [Internet]. Genetics. 2022 ; 220( 1):[citado 2025 maio 18 ] Available from: https://doi.org/10.1093/genetics/iyab183
Vancouver
Colabardini AC, Wang F, Dong Z, Pardeshi L, Rocha MC, Costa JH, Reis TF dos, Brown A, Jaber QZ, Fridman M, Fill T, Rokas A, Malavazi I, Wong KH, Goldman GH. Heterogeneity in the transcriptional response of the human pathogen Aspergillus fumigatus to the antifungal agent caspofungin [Internet]. Genetics. 2022 ; 220( 1):[citado 2025 maio 18 ] Available from: https://doi.org/10.1093/genetics/iyab183
Artigo de periodico
Chemometric optimization of salting-out assisted liquid–liquid extraction (SALLE) combined with LC-MS/MS for the analysis of carvedilol enantiomers in human plasma: application to clinical pharmacokinetics (2022)
Pavan, Marcella; Yamamoto, Priscila; Silva, Rodrigo Moreira da; Salgado Junior, Wilson; Santos, José dos; Kemp, Rafael; Sankarankutty, Ajith Kumar ; Moraes, Natália de; Gaitani, Cristiane de
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP
Subjects: QUIMIOMETRIA, CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS, REPRODUTIBILIDADE DE RESULTADOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAVAN, Marcella et al. Chemometric optimization of salting-out assisted liquid–liquid extraction (SALLE) combined with LC-MS/MS for the analysis of carvedilol enantiomers in human plasma: application to clinical pharmacokinetics. Journal of Chromatography B, v. 1205, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2022.123338. Acesso em: 18 maio 2025.
APA
Pavan, M., Yamamoto, P., Silva, R. M. da, Salgado Junior, W., Santos, J. dos, Kemp, R., et al. (2022). Chemometric optimization of salting-out assisted liquid–liquid extraction (SALLE) combined with LC-MS/MS for the analysis of carvedilol enantiomers in human plasma: application to clinical pharmacokinetics. Journal of Chromatography B, 1205. doi:10.1016/j.jchromb.2022.123338
NLM
Pavan M, Yamamoto P, Silva RM da, Salgado Junior W, Santos J dos, Kemp R, Sankarankutty AK, Moraes N de, Gaitani C de. Chemometric optimization of salting-out assisted liquid–liquid extraction (SALLE) combined with LC-MS/MS for the analysis of carvedilol enantiomers in human plasma: application to clinical pharmacokinetics [Internet]. Journal of Chromatography B. 2022 ; 1205[citado 2025 maio 18 ] Available from: https://doi.org/10.1016/j.jchromb.2022.123338
Vancouver
Pavan M, Yamamoto P, Silva RM da, Salgado Junior W, Santos J dos, Kemp R, Sankarankutty AK, Moraes N de, Gaitani C de. Chemometric optimization of salting-out assisted liquid–liquid extraction (SALLE) combined with LC-MS/MS for the analysis of carvedilol enantiomers in human plasma: application to clinical pharmacokinetics [Internet]. Journal of Chromatography B. 2022 ; 1205[citado 2025 maio 18 ] Available from: https://doi.org/10.1016/j.jchromb.2022.123338
Artigo de periodico
Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli (2022)
Abichabki, Nathália de Lima Martins ; Zacharias, Luísa Vieira; Moreira, Natália Columbaro; Bellíssimo-Rodrigues, Fernando; Moreira, Fernanda L.; Benzi, Jhohann Richard de Lima ; Ogasawara, Tânia Mara Casare; Ferreira, Joseane Cristina; Ribeiro, Camila M.; Pavan, Fernando R.; Pereira, Leonardo Régis Leira; Brancini, Guilherme Thomaz Pereira; Braga, Gilberto Ubida Leite; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Lanchote, Vera Lucia ; Cantón, Rafael; Darini, Ana Lúcia da Costa ; Andrade, Leonardo Neves de
Source: Scientific Reports. Unidades: FMRP, FCFRP
Subjects: CANABINOIDES, REPOSICIONAMENTO DE FÁRMACOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, SINERGISMO DE DROGAS, TESTES DE SENSIBILIDADE MICROBIANA, BACTÉRIAS GRAM-NEGATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABICHABKI, Nathália de Lima Martins et al. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, v. 12, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-10393-8. Acesso em: 18 maio 2025.
APA
Abichabki, N. de L. M., Zacharias, L. V., Moreira, N. C., Bellíssimo-Rodrigues, F., Moreira, F. L., Benzi, J. R. de L., et al. (2022). Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, 12, 1-15. doi:10.1038/s41598-022-10393-8
NLM
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2025 maio 18 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Vancouver
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2025 maio 18 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Artigo de periodico
Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches (2022)
Cruz, Josiane Viana; Giuliatti, Silvana ; Alves, Levy Bueno ; Silva, Rai Campos ; Ferreira, Elenilze Figueiredo Batista; Kimani, Njogu M.; Silva, Carlos Henrique Tomich de Paula da ; Souza, João S. N. de; Espejo-Román, José M.; Santos, Cleydson Breno Rodrigues dos
Source: Journal of Biomolecular Structure and Dynamics. Unidades: FMRP, FCFRP, FFCLRP
Subjects: FARMACOCINÉTICA, TOXICOLOGIA, METABOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZ, Josiane Viana et al. Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches. Journal of Biomolecular Structure and Dynamics, v. 40, n. 12, p. 5386-5408, 2022Tradução . . Disponível em: https://doi.org/10.1080/07391102.2020.1871413. Acesso em: 18 maio 2025.
APA
Cruz, J. V., Giuliatti, S., Alves, L. B., Silva, R. C., Ferreira, E. F. B., Kimani, N. M., et al. (2022). Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches. Journal of Biomolecular Structure and Dynamics, 40( 12), 5386-5408. doi:10.1080/07391102.2020.1871413
NLM
Cruz JV, Giuliatti S, Alves LB, Silva RC, Ferreira EFB, Kimani NM, Silva CHT de P da, Souza JSN de, Espejo-Román JM, Santos CBR dos. Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches [Internet]. Journal of Biomolecular Structure and Dynamics. 2022 ; 40( 12): 5386-5408.[citado 2025 maio 18 ] Available from: https://doi.org/10.1080/07391102.2020.1871413
Vancouver
Cruz JV, Giuliatti S, Alves LB, Silva RC, Ferreira EFB, Kimani NM, Silva CHT de P da, Souza JSN de, Espejo-Román JM, Santos CBR dos. Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches [Internet]. Journal of Biomolecular Structure and Dynamics. 2022 ; 40( 12): 5386-5408.[citado 2025 maio 18 ] Available from: https://doi.org/10.1080/07391102.2020.1871413
Artigo de periodico
Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil (2022)
Peres, Heverton Alves; Martinez, Edson Zangiacomi ; Viana, Carlos Manuel; Pereira, Leonardo Régis Leira
Source: Brazilian Journal of Pharmaceutical Sciences. Unidades: FMRP, FCFRP
Subjects: GLICEMIA, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Heverton Alves et al. Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil. Brazilian Journal of Pharmaceutical Sciences, v. 58, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902022e20985. Acesso em: 18 maio 2025.
APA
Peres, H. A., Martinez, E. Z., Viana, C. M., & Pereira, L. R. L. (2022). Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil. Brazilian Journal of Pharmaceutical Sciences, 58, 1-13. doi:10.1590/s2175-97902022e20985
NLM
Peres HA, Martinez EZ, Viana CM, Pereira LRL. Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-13.[citado 2025 maio 18 ] Available from: https://doi.org/10.1590/s2175-97902022e20985
Vancouver
Peres HA, Martinez EZ, Viana CM, Pereira LRL. Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-13.[citado 2025 maio 18 ] Available from: https://doi.org/10.1590/s2175-97902022e20985
Artigo de periodico
Mesenchymal stromal cells in viral infections: implications for COVID-19 (2021)
Rocha, José Lucas Martins; Oliveira, Waldir César Ferreira de; Noronha, Nádia de Cássia ; Santos, Natalia Cristine Dias dos; Covas, Dimas Tadeu; Picanço-Castro, Virgínia; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Stem Cell Reviews and Reports. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, COVID-19, ADJUVANTES IMUNOLÓGICOS, INSUFICIÊNCIA RESPIRATÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, José Lucas Martins et al. Mesenchymal stromal cells in viral infections: implications for COVID-19. Stem Cell Reviews and Reports, v. 17, n. 1, p. 71-93, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12015-020-10032-7. Acesso em: 18 maio 2025.
APA
Rocha, J. L. M., Oliveira, W. C. F. de, Noronha, N. de C., Santos, N. C. D. dos, Covas, D. T., Picanço-Castro, V., et al. (2021). Mesenchymal stromal cells in viral infections: implications for COVID-19. Stem Cell Reviews and Reports, 17( 1), 71-93. doi:10.1007/s12015-020-10032-7
NLM
Rocha JLM, Oliveira WCF de, Noronha N de C, Santos NCD dos, Covas DT, Picanço-Castro V, Swiech K, Farias KCRM de. Mesenchymal stromal cells in viral infections: implications for COVID-19 [Internet]. Stem Cell Reviews and Reports. 2021 ; 17( 1): 71-93.[citado 2025 maio 18 ] Available from: https://doi.org/10.1007/s12015-020-10032-7
Vancouver
Rocha JLM, Oliveira WCF de, Noronha N de C, Santos NCD dos, Covas DT, Picanço-Castro V, Swiech K, Farias KCRM de. Mesenchymal stromal cells in viral infections: implications for COVID-19 [Internet]. Stem Cell Reviews and Reports. 2021 ; 17( 1): 71-93.[citado 2025 maio 18 ] Available from: https://doi.org/10.1007/s12015-020-10032-7
Artigo de periodico
Isotretinoin-Delonix polymeric nanoparticles: potentials for skin follicular targeting in acne treatment (2021)
Ogunjimi, Abayomi Tolulope; Chahud, Fernando ; Lopez, Renata Fonseca Vianna
Source: International Journal of Pharmaceutics. Unidades: FMRP, FCFRP
Subjects: ACNE VULGAR, RATOS WISTAR, FABACEAE, NANOPARTÍCULAS, PELE DE ANIMAL, SUÍNOS, ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OGUNJIMI, Abayomi Tolulope e CHAHUD, Fernando e LOPEZ, Renata Fonseca Vianna. Isotretinoin-Delonix polymeric nanoparticles: potentials for skin follicular targeting in acne treatment. International Journal of Pharmaceutics, v. 610, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2021.121217. Acesso em: 18 maio 2025.
APA
Ogunjimi, A. T., Chahud, F., & Lopez, R. F. V. (2021). Isotretinoin-Delonix polymeric nanoparticles: potentials for skin follicular targeting in acne treatment. International Journal of Pharmaceutics, 610, 1-12. doi:10.1016/j.ijpharm.2021.121217
NLM
Ogunjimi AT, Chahud F, Lopez RFV. Isotretinoin-Delonix polymeric nanoparticles: potentials for skin follicular targeting in acne treatment [Internet]. International Journal of Pharmaceutics. 2021 ; 610 1-12.[citado 2025 maio 18 ] Available from: https://doi.org/10.1016/j.ijpharm.2021.121217
Vancouver
Ogunjimi AT, Chahud F, Lopez RFV. Isotretinoin-Delonix polymeric nanoparticles: potentials for skin follicular targeting in acne treatment [Internet]. International Journal of Pharmaceutics. 2021 ; 610 1-12.[citado 2025 maio 18 ] Available from: https://doi.org/10.1016/j.ijpharm.2021.121217
Artigo de periodico
Aspergillus fumigatus acetate utilization impacts virulence traits and pathogenicity (2021)
Ries, Laure Nicolas Annick; Castro, Patricia Alves de; Silva, Lilian Pereira ; Valero, Clara; Reis, Thaila Fernanda dos ; Saborano, Raquel; Duarte, Iola F.; Persinoti, Gabriela Felix ; Steenwyk, Jacob L.; Rokas, Antonis Rokas; Almeida, Fausto Bruno dos Reis ; Costa, Jonas Henrique ; Fill, Taicia; Wong, Sarah Sze Wah; Aimanianda, Vishukumar; Rodrigues, Fernando José Santos; Gonçales, Relber A.; Oliveira, Claudio Duarte; Carvalho, Agostinho; Goldman, Gustavo Henrique
Source: mBio. Unidades: FCFRP, FMRP, Interunidades em Bioinformática
Subjects: ASPERGILOSE ANIMAL, ASPERGILLUS, REGULAÇÃO GÊNICA, LARVA, LEPIDOPTERA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIES, Laure Nicolas Annick et al. Aspergillus fumigatus acetate utilization impacts virulence traits and pathogenicity. mBio, v. 12, n. 4, p. 10-20, 2021Tradução . . Disponível em: https://doi.org/10.1128/mbio.01682-21. Acesso em: 18 maio 2025.
APA
Ries, L. N. A., Castro, P. A. de, Silva, L. P., Valero, C., Reis, T. F. dos, Saborano, R., et al. (2021). Aspergillus fumigatus acetate utilization impacts virulence traits and pathogenicity. mBio, 12( 4), 10-20. doi:10.1128/mbio.01682-21
NLM
Ries LNA, Castro PA de, Silva LP, Valero C, Reis TF dos, Saborano R, Duarte IF, Persinoti GF, Steenwyk JL, Rokas AR, Almeida FB dos R, Costa JH, Fill T, Wong SSW, Aimanianda V, Rodrigues FJS, Gonçales RA, Oliveira CD, Carvalho A, Goldman GH. Aspergillus fumigatus acetate utilization impacts virulence traits and pathogenicity [Internet]. mBio. 2021 ; 12( 4): 10-20.[citado 2025 maio 18 ] Available from: https://doi.org/10.1128/mbio.01682-21
Vancouver
Ries LNA, Castro PA de, Silva LP, Valero C, Reis TF dos, Saborano R, Duarte IF, Persinoti GF, Steenwyk JL, Rokas AR, Almeida FB dos R, Costa JH, Fill T, Wong SSW, Aimanianda V, Rodrigues FJS, Gonçales RA, Oliveira CD, Carvalho A, Goldman GH. Aspergillus fumigatus acetate utilization impacts virulence traits and pathogenicity [Internet]. mBio. 2021 ; 12( 4): 10-20.[citado 2025 maio 18 ] Available from: https://doi.org/10.1128/mbio.01682-21

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration